Compare Consolidated Edison, Inc. (ED) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Consolidated Edison, Inc. vs Hinge Health Inc. Class A Common Stock — how do they compare? Consolidated Edison, Inc. trades at $110.91 (market cap $40.53B), while Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B). The key difference: Consolidated Edison, Inc. is far larger — about 4.8× Hinge Health Inc. Class A Common Stock's market cap, and Consolidated Edison, Inc. pays a 3.2% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Consolidated Edison, Inc. for 76 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| ED | HNGE | |
|---|---|---|
Market Cap | $40.53B | $8.47B |
Volume | 2,448,266 | 1,624,526 |
Sector | Utilities | Health |
52-Week High | $115.46 | $105.14 |
52-Week Low | $95.37 | $31.17 |
Typical Hold Time | 76 Days | 0 Days |
Enterprise Value | $67.38B | $8.09B |
Dividend Yield | 3.2% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Consolidated Edison (ED) trades at $107.82, up 0.58% on the day, with a bullish technical signal and strong cash flow from operations of $4.80B in 2025. Recent earnings show mixed results, beating in Q4 2025 and Q2 2026 but missing in Q1 2026. The company maintains solid profitability with a net income margin of 12.53% and recently announced a dividend of $0.89 payable in September 2026, highlighting its status as a Dividend Aristocrat.
ED offers stable utility exposure with consistent dividends, but analyst consensus is cautious with 62.96% hold ratings. Risks include high debt levels and regulatory pressures. The stock's current price near the consensus target of $105.56 suggests limited upside, making it suitable for income-focused investors seeking defensive holdings amid market volatility.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Consolidated Edison, Inc.
Con Ed is a holding company for Consolidated Edison of New York, or CECONY, and Orange & Rockland, or O&R. These utilities provide steam, natural gas, and electricity to customers in southeastern New York—including New York City—and small parts of New Jersey. The two utilities will generate nearly all of Con Ed's earnings once it closes the sale of its clean energy business to RWE. Con Ed's clean energy business owns the second-largest portfolio of utility-scale solar projects in the U.S. Following the sale, Con Ed's only non-utility earnings will come from investments in gas and electric transmission.
Read more on ED →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
